{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:02:53Z","timestamp":1788440573513,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570853"],"award-info":[{"award-number":["81570853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00417-020-04956-6","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T03:10:33Z","timestamp":1602472233000},"page":"661-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization"],"prefix":"10.1007","volume":"259","author":[{"given":"Yixuan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanji","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9405-635X","authenticated-orcid":false,"given":"Bing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"4956_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3940241","volume":"2017","author":"JC Rivera","year":"2017","unstructured":"Rivera JC, Rabah D, Baraa N et al (2017) Ischemic retinopathies: oxidative stress and inflammation. Oxidative Med Cell Longev 2017:1\u201316. https:\/\/doi.org\/10.1155\/2017\/3940241","journal-title":"Oxidative Med Cell Longev"},{"issue":"18","key":"4956_CR2","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1073\/pnas.1523005113","volume":"113","author":"G Hoppe","year":"2016","unstructured":"Hoppe G, Yoon S, Gopalan B et al (2016) Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity. Proc Natl Acad Sci U S A 113(18):2516\u20132525. https:\/\/doi.org\/10.1073\/pnas.1523005113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4956_CR3","doi-asserted-by":"publisher","unstructured":"Bancalari A, Schade R (2020, 2020) Update in the treatment of retinopathy of prematurity. Am J Perinatol. https:\/\/doi.org\/10.1055\/s-0040-1713181","DOI":"10.1055\/s-0040-1713181"},{"key":"4956_CR4","doi-asserted-by":"publisher","unstructured":"Morin J, Luu TM, Superstein R et al (2016) Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics 137(4). https:\/\/doi.org\/10.1542\/peds.2015-3218","DOI":"10.1542\/peds.2015-3218"},{"issue":"1","key":"4956_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40942-017-0084-9","volume":"3","author":"T Cabral","year":"2017","unstructured":"Cabral T, Mello LGM, Lima LH et al (2017) Retinal and choroidal angiogenesis: a review of new targets. Int J Retina Vitreous 3(1):31. https:\/\/doi.org\/10.1186\/s40942-017-0084-9","journal-title":"Int J Retina Vitreous"},{"issue":"13","key":"4956_CR6","doi-asserted-by":"publisher","first-page":"8125","DOI":"10.1167\/iovs.13-12496","volume":"54","author":"S Tremblay","year":"2013","unstructured":"Tremblay S, Miloudi K, Chaychi S et al (2013) Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function. Invest Ophthalmol Vis Sci 54(13):8125\u20138139. https:\/\/doi.org\/10.1167\/iovs.13-12496","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4956_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1203\/00006450-199908000-00010","volume":"46","author":"BN Nandgaonkar","year":"1999","unstructured":"Nandgaonkar BN, Rotschild T, Yu K et al (1999) Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatr Res 46:184\u2013188. https:\/\/doi.org\/10.1203\/00006450-199908000-00010","journal-title":"Pediatr Res"},{"key":"4956_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1006\/mgme.2000.3124","volume":"72","author":"P Yossuck","year":"2001","unstructured":"Yossuck P, Yan Y, Tadesse M et al (2001) Dexamethasone alters TNF-alpha expression in retinopathy. Mol Genet Metab 72:164\u2013167. https:\/\/doi.org\/10.1006\/mgme.2000.3124","journal-title":"Mol Genet Metab"},{"issue":"5","key":"4956_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1076\/ceyr.27.5.309.17222","volume":"27","author":"J Sharma","year":"2003","unstructured":"Sharma J, Barr SM, Yixun G et al (2003) Ibuprofen improves oxygen-induced retinopathy in a mouse model. Curr Eye Res 27(5):309\u2013314. https:\/\/doi.org\/10.1076\/ceyr.27.5.309.17222","journal-title":"Curr Eye Res"},{"issue":"3","key":"4956_CR10","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1167\/iovs.02-0392","volume":"44","author":"L Wilkinson-Berka Jennifer","year":"2003","unstructured":"Wilkinson-Berka Jennifer L, Alousis Nicole S, Kelly Darren J et al (2003) COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 44(3):974\u2013979. https:\/\/doi.org\/10.1167\/iovs.02-0392","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4956_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1167\/iovs.02-0346","volume":"44","author":"K Takahashi","year":"2003","unstructured":"Takahashi K, Saishin Y, Mori K et al (2003) Topical nepafenac inhibits ocular neovascularization. Invest Ophthalmol Vis Sci 44:409\u2013415. https:\/\/doi.org\/10.1167\/iovs.02-0346","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4956_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00417-004-0874-2","volume":"242","author":"S Yoshida","year":"2004","unstructured":"Yoshida S, Yoshida A, Ishibashi T (2004) Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol 242:409\u2013413. https:\/\/doi.org\/10.1007\/s00417-004-0874-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4956_CR13","doi-asserted-by":"publisher","unstructured":"Kociok N, Radetzky S, Krohne TU et al (2006) Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor\u2013deficient mice. Invest Ophthalmol Vis Sci 47(11). https:\/\/doi.org\/10.1167\/iovs.06-0407","DOI":"10.1167\/iovs.06-0407"},{"key":"4956_CR14","first-page":"1586","volume":"42","author":"GA Limb","year":"2001","unstructured":"Limb GA, Hollifield RD, Webster L et al (2001) Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 42:1586\u20131591","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4956_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.exer.2014.03.010","volume":"122","author":"OJ Mezu-Ndubuisi","year":"2014","unstructured":"Mezu-Ndubuisi OJ, Wanek J, Chau FY et al (2014) Correspondence of retinal thinning and vasculopathy in mice with oxygen-induced retinopathy. Exp Eye Res 122:119\u2013122. https:\/\/doi.org\/10.1016\/j.exer.2014.03.010","journal-title":"Exp Eye Res"},{"key":"4956_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/1573397115666190708113601","volume":"15","author":"EM Padilla-Mart","year":"2019","unstructured":"Padilla-Mart EM, Romero SC, Bello-Gualtero JM et al (2019) Drug levels and antibodies against TNF-blockers in spondyloarthritis and rheumatoid arthritis are associated with the activity but they do not predict it. Curr Rheumatol Rev 15:329\u2013335","journal-title":"Curr Rheumatol Rev"},{"key":"4956_CR17","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1080\/14656566.2019.1636032","volume":"20","author":"S D'Adamio","year":"2019","unstructured":"D'Adamio S, Silvaggio D, Massaro A et al (2019) Pharmacotherapeutic management of psoriasis in adolescents and children. Expert Opin Pharmacother 20:1777\u20131785. https:\/\/doi.org\/10.1080\/14656566.2019.1636032","journal-title":"Expert Opin Pharmacother"},{"key":"4956_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/IOP.0000000000000221","volume":"30","author":"L Bartalena","year":"2014","unstructured":"Bartalena L (2014) Commentary: rituximab, adalimumab, etanercept, tocilizumab--are biologics the future for Graves' orbitopathy? Ophthalmic Plast Reconstr Surg 30:420\u2013423. https:\/\/doi.org\/10.1097\/IOP.0000000000000221","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"4956_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.berh.2016.07.005","volume":"30","author":"S Schwartzman","year":"2016","unstructured":"Schwartzman S (2016) Advancements in the management of uveitis. Best Pract Res Clin Rheumatol 30:304\u2013315. https:\/\/doi.org\/10.1016\/j.berh.2016.07.005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4956_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/ijms19030768","volume":"19","author":"H Lim","year":"2018","unstructured":"Lim H, Lee SH, Lee HT et al (2018) Structural biology of the TNF\u03b1 antagonists used in the treatment of rheumatoid arthritis. Int J Mol Sci 19:768. https:\/\/doi.org\/10.3390\/ijms19030768","journal-title":"Int J Mol Sci"},{"key":"4956_CR21","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1167\/iovs.07-0113","volume":"48","author":"J Shen","year":"2007","unstructured":"Shen J, Xie B, Dong A et al (2007) Campochiaro PA. In vivo immunostaining demonstrates macrophages associate with growing and regressing vessels. Invest Ophthalmol Vis Sci 48:4335\u20134341. https:\/\/doi.org\/10.1167\/iovs.07-0113","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4956_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/imm.12571","volume":"147","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Tan W, Demetriades Anna M et al (2016) Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization. Immunology 147:414\u2013428. https:\/\/doi.org\/10.1111\/imm.12571","journal-title":"Immunology"},{"key":"4956_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.exer.2016.02.008","volume":"146","author":"Y Cai","year":"2016","unstructured":"Cai Y, Tan W, Shen X et al (2016) Neutralization of IL-23 depresses experimental ocular neovascularization. Exp Eye Res 146:242\u2013251. https:\/\/doi.org\/10.1016\/j.exer.2016.02.008","journal-title":"Exp Eye Res"},{"key":"4956_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.peptides.2015.04.025","volume":"69","author":"F Yang","year":"2015","unstructured":"Yang F, Bai Y, Jiang Y (2015) Effects of Apelin on RAW264.7 cells under both normal and hypoxic conditions. Peptides 69:133\u2013143. https:\/\/doi.org\/10.1016\/j.peptides.2015.04.025","journal-title":"Peptides"},{"key":"4956_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exer.2013.02.012","volume":"110","author":"M Shirasawa","year":"2013","unstructured":"Shirasawa M, Sonoda S, Terasaki H et al (2013) TNF-\u03b1 disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium. Exp Eye Res 110:59\u201369. https:\/\/doi.org\/10.1016\/j.exer.2013.02.012","journal-title":"Exp Eye Res"},{"key":"4956_CR26","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/eji.201444908","volume":"45","author":"SY Park","year":"2015","unstructured":"Park SY, Lee SW, Kim HY et al (2015) HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1\u03b1 activation. Eur J Immunol 45:1216\u20131227. https:\/\/doi.org\/10.1002\/eji.201444908","journal-title":"Eur J Immunol"},{"key":"4956_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/19420862.2017.1388483","volume":"10","author":"B Hassett","year":"2018","unstructured":"Hassett B, Singh E, Mahgoub E et al (2018) Manufacturing history of etanercept (Enbrel): consistency of product quality through major process revisions. MAbs 10:159\u2013165. https:\/\/doi.org\/10.1080\/19420862.2017.1388483","journal-title":"MAbs"},{"key":"4956_CR28","first-page":"1072","volume":"34","author":"BA Fisher","year":"2016","unstructured":"Fisher BA, Donatien P, Filer A et al (2016) Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis. Clin. Exp Rheumatol 34:1072\u20131076","journal-title":"Exp Rheumatol"},{"key":"4956_CR29","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.autrev.2017.04.005","volume":"16","author":"A Leblond","year":"2017","unstructured":"Leblond A, Allanore Y, Avouac J (2017) Targeting synovial neoangiogenesis in rheumatoid arthritis. Autoimmun Rev 16:594\u2013601. https:\/\/doi.org\/10.1016\/j.autrev.2017.04.005","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4956_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.2287","volume":"214","author":"JR Bradley","year":"2008","unstructured":"Bradley JR (2008) TNF-Mediated inflammatory disease. J Pathol 214(2):149\u2013160. https:\/\/doi.org\/10.1002\/path.2287","journal-title":"J Pathol"},{"key":"4956_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/s0962-8924(01)02064-5","volume":"11","author":"V Baud","year":"2001","unstructured":"Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372\u2013377. https:\/\/doi.org\/10.1016\/s0962-8924(01)02064-5","journal-title":"Trends Cell Biol"},{"issue":"4","key":"4956_CR32","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/sj.bjp.0704549","volume":"135","author":"DJ MacEwan","year":"2002","unstructured":"MacEwan DJ (2002) TNF ligands and receptors-a matter of life and death. Br J Pharmacol 135(4):855\u2013875. https:\/\/doi.org\/10.1038\/sj.bjp.0704549","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4956_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-2187-8-7","volume":"8","author":"P Xie","year":"2013","unstructured":"Xie P (2013) TRAF molecules in cell signaling and in human diseases. J Mol Signal 8(1):1\u201331. https:\/\/doi.org\/10.1186\/1750-2187-8-7","journal-title":"J Mol Signal"},{"issue":"Pt 4","key":"4956_CR34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/jcs.115.4.679","volume":"115","author":"JY Chung","year":"2002","unstructured":"Chung JY, Park YC, Ye H et al (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115(Pt 4):679\u2013688","journal-title":"J Cell Sci"},{"issue":"1","key":"4956_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12311","volume":"266","author":"XD Yang","year":"2015","unstructured":"Yang XD, Sun SC (2015) Targeting signaling factors for degradation, an emerging mechanism for TRAF functions. Immunol Rev 266(1):56\u201371. https:\/\/doi.org\/10.1111\/imr.12311","journal-title":"Immunol Rev"},{"key":"4956_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4251\/wjgo.v11.i4.281","volume":"11","author":"AFT Rossi","year":"2019","unstructured":"Rossi AFT, Contiero JC, Manoel-Caetano FS et al (2019) Up-regulation of tumor necrosis factor-\u03b1 pathway survival genes and of the receptor TNFR2 in gastric cancer. World J Gastrointest Oncol 11:281\u2013294. https:\/\/doi.org\/10.4251\/wjgo.v11.i4.281","journal-title":"World J Gastrointest Oncol"},{"key":"4956_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/1751-2980.12044","volume":"14","author":"YQ Qiao","year":"2013","unstructured":"Qiao YQ, Shen J, Gu Y et al (2013) Gene expression of tumor necrosis factor receptor associated-factor (TRAF)-1 and TRAF-2 in inflammatory bowel disease. J Dig Dis 14:244\u2013250. https:\/\/doi.org\/10.1111\/1751-2980.12044","journal-title":"J Dig Dis"},{"key":"4956_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/CMR.0000000000000553","volume":"29","author":"S Romano","year":"2019","unstructured":"Romano S, D'Arrigo P, Tufano M et al (2019) TRAF2 and FKBP51 as possible markers for identification of suitable melanoma tumors for tumor necrosis factor-\u03b1 inhibition. Melanoma Res 29:145\u2013150. https:\/\/doi.org\/10.1097\/CMR.0000000000000553","journal-title":"Melanoma Res"},{"key":"4956_CR39","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.12659\/msm.903397","volume":"23","author":"W Zhang","year":"2017","unstructured":"Zhang W, Sun Y, Liu L et al (2017) Prognostic significance of TNFR-associated factor 1 and 2 (TRAF1 and TRAF2) in glioblastoma. Med Sci Monit 23:4506\u20134512. https:\/\/doi.org\/10.12659\/msm.903397","journal-title":"Med Sci Monit"},{"issue":"1","key":"4956_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bjo.2008.142646","volume":"93","author":"T Sato","year":"2009","unstructured":"Sato T, Kusaka S, Hashida N et al (2009) Comprehensive gene-expression profile in murine oxygen-induced retinopathy. Br J Ophthalmol 93(1):96\u2013103. https:\/\/doi.org\/10.1136\/bjo.2008.142646","journal-title":"Br J Ophthalmol"},{"key":"4956_CR41","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1073\/pnas.87.8.3127","volume":"87","author":"M Brockhaus","year":"1990","unstructured":"Brockhaus M, Schoenfeld HJ, Schlaeger EJ et al (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci U S A 87:3127\u20133131. https:\/\/doi.org\/10.1073\/pnas.87.8.3127","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4956_CR42","first-page":"27","volume":"146","author":"JR Bradley","year":"1995","unstructured":"Bradley JR, Thiru S, Pober JS (1995) Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 146:27\u201332","journal-title":"Am J Pathol"},{"key":"4956_CR43","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.ophtha.2009.04.026","volume":"116","author":"T Sato","year":"2009","unstructured":"Sato T, Kusaka S, Shimojo H et al (2009) Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology 116:2165\u20132169. https:\/\/doi.org\/10.1016\/j.ophtha.2009.04.026","journal-title":"Ophthalmology"},{"key":"4956_CR44","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1167\/iovs.10-5798","volume":"52","author":"K Kataoka","year":"2011","unstructured":"Kataoka K, Nishiguchi KM, Kaneko H et al (2011) The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization. Invest Ophthalmol Vis Sci 52:1431\u20131438. https:\/\/doi.org\/10.1167\/iovs.10-5798","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4956_CR45","first-page":"4516","volume":"59","author":"M Suganuma","year":"1999","unstructured":"Suganuma M, Okabe S, Marino MW et al (1999) Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res 59:4516\u20134518","journal-title":"Cancer Res"},{"key":"4956_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.lfs.2008.09.029","volume":"83","author":"XY Zhu","year":"2008","unstructured":"Zhu XY, Daghini E, Chade AR et al (2008) Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. Life Sci 83:801\u2013809. https:\/\/doi.org\/10.1016\/j.lfs.2008.09.029","journal-title":"Life Sci"},{"key":"4956_CR47","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/329630a0","volume":"329","author":"SJ Leibovich","year":"1987","unstructured":"Leibovich SJ, Polverini PJ, Shepard HM et al (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329:630\u2013632. https:\/\/doi.org\/10.1038\/329630a0","journal-title":"Nature"},{"issue":"5","key":"4956_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0955-2235(92)90027-f","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9(5):361\u2013371. https:\/\/doi.org\/10.1016\/0955-2235(92)90027-f","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4956_CR49","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","volume":"72","author":"BB Aggarwal","year":"2006","unstructured":"Aggarwal BB, Shishodia S, Sandur SK et al (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72(11):1605\u20131621. https:\/\/doi.org\/10.1016\/j.bcp.2006.06.029","journal-title":"Biochem Pharmacol"},{"key":"4956_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jdermsci.2017.03.004","volume":"86","author":"SC Tang","year":"2017","unstructured":"Tang SC, Liao PY, Hung SJ et al (2017) Topical application of glycolic acid suppresses the UVB induced IL-6, IL-8, MCP-1 and COX-2 inflammation by modulating NF-\u03baB signaling pathway in keratinocytes and mice skin. J Dermatol Sci 86:238\u2013248. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.03.004","journal-title":"J Dermatol Sci"},{"key":"4956_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11418-016-1064-3","volume":"71","author":"WX Sun","year":"2017","unstructured":"Sun WX, Liu Y, Zhou W et al (2017) Shikonin inhibits TNF-\u03b1 production through suppressing PKC-NF-\u03baB-dependent decrease of IL-10 in rheumatoid arthritis-like cell model. J Nat Med 71:349\u2013356. https:\/\/doi.org\/10.1007\/s11418-016-1064-3","journal-title":"J Nat Med"},{"key":"4956_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1006\/bbrc.2000.2308","volume":"269","author":"H Kim","year":"2000","unstructured":"Kim H, Koh G (2000) Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. Biochem Biophys Res Commun 269:401\u2013405. https:\/\/doi.org\/10.1006\/bbrc.2000.2308","journal-title":"Biochem Biophys Res Commun"},{"key":"4956_CR53","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.1167\/iovs.14-14874","volume":"55","author":"RA Kowluru","year":"2014","unstructured":"Kowluru RA, Santos JM, Zhong Q (2014) Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy. Invest Ophthalmol Vis Sci 55:5653\u20135660. https:\/\/doi.org\/10.1167\/iovs.14-14874","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4956_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.biocel.2009.10.006","volume":"42","author":"P Sapieha","year":"2010","unstructured":"Sapieha P, Hamel D, Shao Z et al (2010) Proliferative retinopathies: angiogenesis that blinds. Int J Biochem Cell Biol 42:5\u201312. https:\/\/doi.org\/10.1016\/j.biocel.2009.10.006","journal-title":"Int J Biochem Cell Biol"},{"key":"4956_CR55","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.106.647255","volume":"115","author":"DA Goukassian","year":"2007","unstructured":"Goukassian DA, Qin G, Dolan C et al (2007) Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 115:752\u2013762. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.647255","journal-title":"Circulation"},{"key":"4956_CR56","doi-asserted-by":"publisher","first-page":"37623","DOI":"10.1074\/jbc.M508356200","volume":"280","author":"JL Parra","year":"2005","unstructured":"Parra JL, Buxade M, Proud CG (2005) Features of the catalytic domains and C termini of the MAPK signal-integrating kinases Mnk1 and Mnk2 determine their differing activities and regulatory properties. J Biol Chem 280:37623\u201337633. https:\/\/doi.org\/10.1074\/jbc.M508356200","journal-title":"J Biol Chem"},{"key":"4956_CR57","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","volume":"49","author":"T Horiuchi","year":"2010","unstructured":"Horiuchi T, Mitoma H, Harashima S et al (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49:1215\u20131228. https:\/\/doi.org\/10.1093\/rheumatology\/keq031","journal-title":"Rheumatology (Oxford)"},{"key":"4956_CR58","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cytogfr.2004.03.011","volume":"15","author":"G Eissner","year":"2004","unstructured":"Eissner G, Kolch W, Scheurich P (2004) Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev 15:353\u2013366. https:\/\/doi.org\/10.1016\/j.cytogfr.2004.03.011","journal-title":"Cytokine Growth Factor Rev"},{"key":"4956_CR59","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1167\/iovs.17-22945","volume":"59","author":"T Su","year":"2018","unstructured":"Su T, Zhong Y, Demetriades AM et al (2018) Endocan blockade suppresses experimental ocular neovascularization in mice. Invest Ophthalmol Vis Sci 59:930\u2013939. https:\/\/doi.org\/10.1167\/iovs.17-22945","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4956_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbcan.2009.02.004","volume":"1796","author":"SB Coffelt","year":"2009","unstructured":"Coffelt SB, Hughes R, Lewis CE (2009) Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 1796(1):11\u201318. https:\/\/doi.org\/10.1016\/j.bbcan.2009.02.004","journal-title":"Biochim Biophys Acta"},{"key":"4956_CR61","doi-asserted-by":"publisher","first-page":"d1030","DOI":"10.2741\/1056","volume":"8","author":"A Madan","year":"2003","unstructured":"Madan A, Penn JS (2003) Animal models of oxygen-induced retinopathy. Front Biosci 8:d1030\u2013d1043. https:\/\/doi.org\/10.2741\/1056","journal-title":"Front Biosci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-04956-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T09:10:42Z","timestamp":1634029842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-04956-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4956"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04956-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal-related procedures described here were in accordance with the National Institutes of Health Guide for the Use and Care of Laboratory Animals. The experiment protocol was approved by the Animal Care and Use Committee of Shanghai Jiao Tong University School of Medicine. Animals used in this study were specific pathogen-free C57BL\/6 mice. We ensured to minimize animal suffering and the number of animals used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal models and ethical approval"}}]}}